✦ LIBER ✦

Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of l-Dopa in parkinsonian monkeys

✍ Scribed by Laurent Grégoire; Pershia Samadi; Julie Graham; Paul J. Bédard; Gerd D. Bartoszyk; Thérèse Di Paolo

Book ID: 116820596
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 898 KB
Volume: 15
Category: Article
ISSN: 1353-8020
DOI: 10.1016/j.parkreldis.2008.11.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safinamide reduces dyskinesias and prolo

Safinamide reduces dyskinesias and prolongs l-DOPA antiparkinsonian effect in parkinsonian monkeys

✍ Grégoire, Laurent; Jourdain, Vincent A.; Townsend, Matthew; Roach, Arthur; Di Pa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 922 KB

Chronic treatment with small doses of ca

Chronic treatment with small doses of cabergoline prevents dopa-induced dyskinesias in parkinsonian monkeys

✍ Nancy Bélanger; Laurent Grégoire; Abdallah Hadj Tahar; Paul J. Bédard 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract Levodopa continues to be the most effective agent for the symptomatic treatment of Parkinson's disease (PD). But over time, initial benefits decline in efficacy because of a rise in adverse effects such as dyskinesias. The pathophysiology of levodopa‐induced dyskinesias (LID) is not com

AQW051, a novel and selective nicotinic

AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys

✍ Di Paolo, Thérèse; Grégoire, Laurent; Feuerbach, Dominik; Elbast, Walid; Weiss, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 856 KB

The acute antiparkinsonian and antidyski

The acute antiparkinsonian and antidyskinetic effect of AFQ056, a novel metabotropic glutamate receptor type 5 antagonist, in l-Dopa-treated parkinsonian monkeys

✍ Laurent Grégoire; Nicolas Morin; Bazoumana Ouattara; Fabrizio Gasparini; Graeme 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 887 KB

The partial 5-HT1A agonist buspirone red

The partial 5-HT1A agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy

✍ Karen L. Eskow; Vikas Gupta; Salmahn Alam; John Y. Park; Christopher Bishop 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 535 KB

The α2-adrenergic receptor antagonist id

The α2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease

✍ Brian Henry; Susan H. Fox; David Peggs; Alan R. Crossman; Jonathan M. Brotchie 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views